{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:05:00Z","timestamp":1792202700175,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018530","name":"Major Science and Technology Projects in Anhui Province","doi-asserted-by":"publisher","award":["202303a07020004"],"award-info":[{"award-number":["202303a07020004"]}],"id":[{"id":"10.13039\/501100018530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2022HSC\\u2013CIP001"],"award-info":[{"award-number":["2022HSC\\u2013CIP001"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF0705002"],"award-info":[{"award-number":["2022YFF0705002"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3400502"],"award-info":[{"award-number":["2022YFC3400502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009076","name":"University of Science and Technology of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.actbio.2025.10.018","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:31:19Z","timestamp":1760164279000},"page":"591-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Tuning the polyethylene glycol-lipid anchor length of lipid nanoparticles to enhance brain-targeted siRNA delivery"],"prefix":"10.1016","volume":"207","author":[{"given":"Haiyang","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zesen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6139-2025","authenticated-orcid":false,"given":"Dongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaru","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1679-8718","authenticated-orcid":false,"given":"Baoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-900X","authenticated-orcid":false,"given":"Changlin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.actbio.2025.10.018_bib0001","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","volume":"35","author":"Alexander","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.actbio.2025.10.018_bib0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.actbio.2025.10.018_bib0003","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molmed.2023.02.004","article-title":"Brain gene therapy with Trojan horse lipid nanoparticles","volume":"29","author":"Pardridge","year":"2023","journal-title":"Trends. Mol. Med."},{"issue":"5","key":"10.1016\/j.actbio.2025.10.018_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.actbio.2025.10.018_bib0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2013developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.actbio.2025.10.018_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-022-01298-z","article-title":"Nucleic acid drug vectors for diagnosis and treatment of brain diseases","volume":"8","author":"Lu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.actbio.2025.10.018_bib0007","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"51","key":"10.1016\/j.actbio.2025.10.018_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.actbio.2025.10.018_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308029","article-title":"Engineered mRNA delivery systems for biomedical applications","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.actbio.2025.10.018_bib0010","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1093\/nar\/gkae368","article-title":"A programmable dual-targeting siRNA scaffold supports potent two-gene modulation in the central nervous system","volume":"52","author":"Belgrad","year":"2024","journal-title":"Nucleic. Acids. Res."},{"issue":"24","key":"10.1016\/j.actbio.2025.10.018_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202000416","article-title":"Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment","volume":"32","author":"Zou","year":"2020","journal-title":"Adv. Mater."},{"issue":"41","key":"10.1016\/j.actbio.2025.10.018_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202404234","article-title":"Lipid nanoparticles: versatile drug delivery vehicles for traversing the blood brain barrier to treat brain cancer","volume":"34","author":"Cai","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2025.10.018_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.824299","article-title":"Small interfering RNA for Gliomas treatment: overcoming hurdles in delivery","volume":"10","author":"Teng","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.actbio.2025.10.018_bib0014","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"10.1016\/j.actbio.2025.10.018_bib0015","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized nanomaterials capable of crossing the blood-brain barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS. Nano"},{"key":"10.1016\/j.actbio.2025.10.018_bib0016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.actbio.2025.10.018_bib0017","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3390\/pharmaceutics14122682","article-title":"Recent advances in lipid nanoparticles for delivery of mRNA","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.actbio.2025.10.018_bib0018","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"issue":"11","key":"10.1016\/j.actbio.2025.10.018_bib0019","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles horizontal line from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS. Nano"},{"key":"10.1016\/j.actbio.2025.10.018_bib0020","article-title":"Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery","volume":"8","author":"Haque","year":"2024","journal-title":"Int. J. Pharm.: X"},{"issue":"11","key":"10.1016\/j.actbio.2025.10.018_bib0021","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/pharmaceutics14112520","article-title":"siRNA functionalized lipid nanoparticles (LNPs) in management of diseases","volume":"14","author":"Kalita","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.actbio.2025.10.018_bib0022","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.actbio.2025.10.018_bib0023","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood-brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.10.018_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114861","article-title":"Lipid nanoparticle-mediated drug delivery to the brain","volume":"197","author":"Khare","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.10.018_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113641","article-title":"Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases","volume":"381","author":"Moosavi","year":"2025","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.actbio.2025.10.018_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.110228","article-title":"Systemically intravenous siRNA delivery into brain with a targeting and efficient polypeptide carrier and its evaluation on anti-glioma efficacy","volume":"36","author":"Chen","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"5","key":"10.1016\/j.actbio.2025.10.018_bib0027","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acs.nanolett.3c03509","article-title":"Predictive high-throughput platform for dual screening of mRNA lipid nanoparticle blood-brain barrier transfection and crossing","volume":"24","author":"Han","year":"2024","journal-title":"Nano Lett."},{"issue":"10","key":"10.1016\/j.actbio.2025.10.018_bib0028","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3390\/vaccines12101148","article-title":"Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines. (Basel)"},{"issue":"1","key":"10.1016\/j.actbio.2025.10.018_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.actbio.2025.10.018_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jconrel.2024.04.022","article-title":"Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies - challenges and opportunities","volume":"370","author":"Simonsen","year":"2024","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.actbio.2025.10.018_bib0031","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"1","key":"10.1016\/j.actbio.2025.10.018_bib0032","first-page":"35","article-title":"Membrane-destabilizing ionizable lipid empowered imaging-guided siRNA delivery and cancer treatment","volume":"1","author":"Guo","year":"2021","journal-title":"Explor. (Beijing China)"},{"key":"10.1016\/j.actbio.2025.10.018_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.10.018_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119792","article-title":"PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: faster PEG shedding attenuates anti-PEG IgM production","volume":"588","author":"Suzuki","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.actbio.2025.10.018_bib0035","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.actbio.2025.10.018_bib0036","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymthe.2005.09.014","article-title":"Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes","volume":"13","author":"Judge","year":"2006","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.actbio.2025.10.018_bib0037","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1039\/D1NA00712B","article-title":"Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing","volume":"4","author":"Sarode","year":"2022","journal-title":"Nanoscale Adv."},{"issue":"2","key":"10.1016\/j.actbio.2025.10.018_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101457","article-title":"Ionizable lipid nanoparticles with functionalized PEG-lipids increase retention in the tumor microenvironment","volume":"33","author":"Jester","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.actbio.2025.10.018_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114726","article-title":"From in vitro to in vivo: the dominant role of PEG-lipids in LNP performance","volume":"212","author":"Borah","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2025.10.018_bib0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2025.01.071","article-title":"Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines","volume":"380","author":"Zhang","year":"2025","journal-title":"J. Control Release"},{"issue":"18","key":"10.1016\/j.actbio.2025.10.018_bib0041","doi-asserted-by":"crossref","first-page":"11329","DOI":"10.1039\/D5NR00433K","article-title":"PEGylated lipid screening, composition optimization, and structure-activity relationship determination for lipid nanoparticle-mediated mRNA delivery","volume":"17","author":"Liu","year":"2025","journal-title":"Nanoscale"},{"issue":"12","key":"10.1016\/j.actbio.2025.10.018_bib0042","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic. Acids"},{"issue":"7","key":"10.1016\/j.actbio.2025.10.018_bib0043","doi-asserted-by":"crossref","first-page":"746","DOI":"10.7150\/thno.10732","article-title":"Effect of PEG pairing on the efficiency of cancer-targeting liposomes","volume":"5","author":"Saw","year":"2015","journal-title":"Theranostics."},{"key":"10.1016\/j.actbio.2025.10.018_bib0044","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2024.06.005","article-title":"PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting","volume":"372","author":"Du","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.actbio.2025.10.018_bib0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12951-024-02812-x","article-title":"Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA","volume":"22","author":"Kong","year":"2024","journal-title":"J. Nanobiotechnology"},{"issue":"2","key":"10.1016\/j.actbio.2025.10.018_bib0046","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/pharmaceutics15020597","article-title":"Effect of PEG anchor and serum on lipid nanoparticles: development of a nanoparticles tracking method","volume":"15","author":"Berger","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.actbio.2025.10.018_bib0047","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s12274-023-6031-1","article-title":"Scalable synthesis of lipid nanoparticles for nucleic acid drug delivery using an isometric channel-size enlarging strategy","volume":"17","author":"Ma","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.actbio.2025.10.018_bib0048","doi-asserted-by":"crossref","first-page":"8395","DOI":"10.2147\/IJN.S188016","article-title":"Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting","volume":"13","author":"Shobaki","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2025.10.018_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121645","article-title":"An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy","volume":"287","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"issue":"30","key":"10.1016\/j.actbio.2025.10.018_bib0050","doi-asserted-by":"crossref","first-page":"eabb4429","DOI":"10.1126\/sciadv.abb4429","article-title":"Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection","volume":"6","author":"Ma","year":"2020","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.actbio.2025.10.018_bib0051","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/acschembio.5c00039","article-title":"Optimizing peptide-conjugated lipid nanoparticles for efficient siRNA delivery across the blood-brain barrier and treatment of glioblastoma multiforme","volume":"20","author":"Tong","year":"2025","journal-title":"ACS Chem, Biol."},{"issue":"9","key":"10.1016\/j.actbio.2025.10.018_bib0052","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The biomolecular corona of lipid nanoparticles for gene therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.actbio.2025.10.018_bib0053","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes","volume":"54","author":"Gabizon","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2025.10.018_bib0054","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.actbio.2025.10.018_bib0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41420-023-01302-7","article-title":"PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death. Discov."},{"issue":"6","key":"10.1016\/j.actbio.2025.10.018_bib0056","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/stem.1081","article-title":"Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice","volume":"30","author":"Lee","year":"2012","journal-title":"Stem. Cells"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125007627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125007627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:48:26Z","timestamp":1773330506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125007627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":56,"alternative-id":["S1742706125007627"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.10.018","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuning the polyethylene glycol-lipid anchor length of lipid nanoparticles to enhance brain-targeted siRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}